<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1996-02-01" modified="2017-11-22" version="182">
<accession>P45974</accession>
<accession>D3DUS7</accession>
<accession>D3DUS8</accession>
<accession>Q96J22</accession>
<name>UBP5_HUMAN</name>
<protein>
<recommendedName>
<fullName>Ubiquitin carboxyl-terminal hydrolase 5</fullName>
<ecNumber>3.4.19.12</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Deubiquitinating enzyme 5</fullName>
</alternativeName>
<alternativeName>
<fullName>Isopeptidase T</fullName>
</alternativeName>
<alternativeName>
<fullName>Ubiquitin thioesterase 5</fullName>
</alternativeName>
<alternativeName>
<fullName>Ubiquitin-specific-processing protease 5</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">USP5</name>
<name type="synonym">ISOT</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1995" name="FEBS Lett." volume="376" first="233" last="237">
<title>cDNA cloning of a human 100 kDa de-ubiquitinating enzyme: the 100 kDa human de-ubiquitinase belongs to the ubiquitin C-terminal hydrolase family 2 (UCH2).</title>
<authorList>
<person name="Falquet L."/>
<person name="Paquet N."/>
<person name="Frutiger S."/>
<person name="Hughes G.J."/>
<person name="Hoang-Van K."/>
<person name="Jaton J.-C."/>
</authorList>
<dbReference type="PubMed" id="7498549"/>
<dbReference type="DOI" id="10.1016/0014-5793(95)01287-7"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1996" name="Genome Res." volume="6" first="314" last="326">
<title>A gene-rich cluster between the CD4 and triosephosphate isomerase genes at human chromosome 12p13.</title>
<authorList>
<person name="Ansari-Lari M.A."/>
<person name="Muzny D.M."/>
<person name="Lu J."/>
<person name="Lu F."/>
<person name="Lilley C.E."/>
<person name="Spanos S."/>
<person name="Malley T."/>
<person name="Gibbs R.A."/>
</authorList>
<dbReference type="PubMed" id="8723724"/>
<dbReference type="DOI" id="10.1101/gr.6.4.314"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1997" name="Genome Res." volume="7" first="268" last="280">
<title>Large-scale sequencing in human chromosome 12p13: experimental and computational gene structure determination.</title>
<authorList>
<person name="Ansari-Lari M.A."/>
<person name="Shen Y."/>
<person name="Muzny D.M."/>
<person name="Lee W."/>
<person name="Gibbs R.A."/>
</authorList>
<dbReference type="PubMed" id="9074930"/>
<dbReference type="DOI" id="10.1101/gr.7.3.268"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="submission" date="1995-11" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Tashayev V.L."/>
<person name="O'Connor L.B."/>
<person name="Larsen C.N."/>
<person name="Kasperek E."/>
<person name="Pickart C.M."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="5">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS LONG AND SHORT)</scope>
<source>
<tissue>Kidney</tissue>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1995" name="FEBS Lett." volume="359" first="73" last="77">
<title>A human de-ubiquitinating enzyme with both isopeptidase and peptidase activities in vitro.</title>
<authorList>
<person name="Falquet L."/>
<person name="Paquet N."/>
<person name="Frutiger S."/>
<person name="Hughes G.J."/>
<person name="Hoang-Van K."/>
<person name="Jaton J.-C."/>
</authorList>
<dbReference type="PubMed" id="7851534"/>
<dbReference type="DOI" id="10.1016/0014-5793(94)01451-6"/>
</citation>
<scope>CHARACTERIZATION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="19581" last="19592">
<title>Recognition of polyubiquitin isoforms by the multiple ubiquitin binding modules of isopeptidase T.</title>
<authorList>
<person name="Reyes-Turcu F.E."/>
<person name="Shanks J.R."/>
<person name="Komander D."/>
<person name="Wilkinson K.D."/>
</authorList>
<dbReference type="PubMed" id="18482987"/>
<dbReference type="DOI" id="10.1074/jbc.M800947200"/>
</citation>
<scope>MUTAGENESIS OF ARG-221; CYS-335; ASP-435; MET-666 AND MET-734</scope>
<scope>POLYUBIQUITIN BINDING</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="5030" last="5041">
<title>Suppression of the deubiquitinating enzyme USP5 causes the accumulation of unanchored polyubiquitin and the activation of p53.</title>
<authorList>
<person name="Dayal S."/>
<person name="Sparks A."/>
<person name="Jacob J."/>
<person name="Allende-Vega N."/>
<person name="Lane D.P."/>
<person name="Saville M.K."/>
</authorList>
<dbReference type="PubMed" id="19098288"/>
<dbReference type="DOI" id="10.1074/jbc.M805871200"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-783</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-783</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2011" name="PLoS ONE" volume="6" first="E29362" last="E29362">
<title>Domain analysis reveals that a deubiquitinating enzyme USP13 performs non-activating catalysis for Lys63-linked polyubiquitin.</title>
<authorList>
<person name="Zhang Y.H."/>
<person name="Zhou C.J."/>
<person name="Zhou Z.R."/>
<person name="Song A.X."/>
<person name="Hu H.Y."/>
</authorList>
<dbReference type="PubMed" id="22216260"/>
<dbReference type="DOI" id="10.1371/journal.pone.0029362"/>
</citation>
<scope>MUTAGENESIS OF 221-ARG--TYR-223 AND TYR-261</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="M111.015131" last="M111.015131">
<title>Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features.</title>
<authorList>
<person name="Bienvenut W.V."/>
<person name="Sumpton D."/>
<person name="Martinez A."/>
<person name="Lilla S."/>
<person name="Espagne C."/>
<person name="Meinnel T."/>
<person name="Giglione C."/>
</authorList>
<dbReference type="PubMed" id="22223895"/>
<dbReference type="DOI" id="10.1074/mcp.M111.015131"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-292; SER-779; SER-783 AND SER-785</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-156</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2006" name="Cell" volume="124" first="1197" last="1208">
<title>The ubiquitin binding domain ZnF UBP recognizes the C-terminal diglycine motif of unanchored ubiquitin.</title>
<authorList>
<person name="Reyes-Turcu F.E."/>
<person name="Horton J.R."/>
<person name="Mullally J.E."/>
<person name="Heroux A."/>
<person name="Cheng X."/>
<person name="Wilkinson K.D."/>
</authorList>
<dbReference type="PubMed" id="16564012"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.02.038"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.09 ANGSTROMS) OF 163-291 IN COMPLEX WITH UBIQUITIN</scope>
<scope>ZINC-BINDING</scope>
<scope>MUTAGENESIS OF CYS-199; CYS-202; CYS-219 AND HIS-232</scope>
</reference>
<reference key="22">
<citation type="submission" date="2006-06" db="PDB data bank">
<title>Solution structure of the first and second UBA domains in the human ubiquitin specific protease 5 (isopeptidase 5).</title>
<authorList>
<consortium name="RIKEN structural genomics initiative (RSGI)"/>
</authorList>
</citation>
<scope>STRUCTURE BY NMR OF 655-772</scope>
</reference>
<reference key="23">
<citation type="submission" date="2009-12" db="PDB data bank">
<title>Covalent ubiquitin-USP5 complex.</title>
<authorList>
<person name="Walker J.R."/>
<person name="Avvakumov G.V."/>
<person name="Xue S."/>
<person name="Butler-Cole C."/>
<person name="Weigelt J."/>
<person name="Bountra C."/>
<person name="Arrowsmith C.H."/>
<person name="Edwards A.M."/>
<person name="Bochkarev A."/>
<person name="Dhe-Paganon S."/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 1-858 IN COMPLEX WITH UBIQUITIN</scope>
<scope>DISULFIDE BOND</scope>
<scope>ZINC-BINDING</scope>
</reference>
<comment type="function">
<text evidence="18">Cleaves linear and branched multiubiquitin polymers with a marked preference for branched polymers. Involved in unanchored 'Lys-48'-linked polyubiquitin disassembly. Binds linear and 'Lys-63'-linked polyubiquitin with a lower affinity. Knock-down of USP5 causes the accumulation of p53/TP53 and an increase in p53/TP53 transcriptional activity because the unanchored polyubiquitin that accumulates is able to compete with ubiquitinated p53/TP53 but not with MDM2 for proteasomal recognition.</text>
</comment>
<comment type="catalytic activity">
<text>Thiol-dependent hydrolysis of ester, thioester, amide, peptide and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76-residue protein attached to proteins as an intracellular targeting signal).</text>
</comment>
<comment type="subunit">
<text evidence="10">Interacts with TRIML1.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-741277"/>
<interactant intactId="EBI-724310">
<id>Q15038</id>
<label>DAZAP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-741277"/>
<interactant intactId="EBI-954531">
<id>P54727</id>
<label>RAD23B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-741277"/>
<interactant intactId="EBI-473249">
<id>O75528</id>
<label>TADA3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-741277"/>
<interactant intactId="EBI-9675724">
<id>Q8WW34</id>
<label>TMEM239</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P45974-1</id>
<name>Long</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P45974-2</id>
<name>Short</name>
<sequence type="described" ref="VSP_005259"/>
</isoform>
</comment>
<comment type="domain">
<text>The UBP-type zinc finger domain interacts selectively with an unmodified C-terminus of the proximal ubiquitin. Both UBA domains are involved in polyubiquitin recognition.</text>
</comment>
<comment type="miscellaneous">
<text>The UBP-type zinc finger domain crystallizes as a dimer linked by a disulfide bond between the Cys-195 residues of both molecules, but there is no evidence that the full-length USP5 exists as a dimer.</text>
</comment>
<comment type="similarity">
<text evidence="22">Belongs to the peptidase C19 family.</text>
</comment>
<dbReference type="EC" id="3.4.19.12"/>
<dbReference type="EMBL" id="X91349">
<property type="protein sequence ID" value="CAA62690.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U47927">
<property type="protein sequence ID" value="AAC50465.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U47924">
<property type="protein sequence ID" value="AAB51314.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U47924">
<property type="protein sequence ID" value="AAB51315.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U35116">
<property type="protein sequence ID" value="AAA78934.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471116">
<property type="protein sequence ID" value="EAW88724.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471116">
<property type="protein sequence ID" value="EAW88725.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471116">
<property type="protein sequence ID" value="EAW88726.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471116">
<property type="protein sequence ID" value="EAW88727.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC004889">
<property type="protein sequence ID" value="AAH04889.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC005139">
<property type="protein sequence ID" value="AAH05139.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS31733.1">
<molecule id="P45974-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS41743.1">
<molecule id="P45974-1"/>
</dbReference>
<dbReference type="PIR" id="S68227">
<property type="entry name" value="S68227"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001092006.1">
<molecule id="P45974-1"/>
<property type="nucleotide sequence ID" value="NM_001098536.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003472.2">
<molecule id="P45974-2"/>
<property type="nucleotide sequence ID" value="NM_003481.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.631661"/>
<dbReference type="PDB" id="2DAG">
<property type="method" value="NMR"/>
<property type="chains" value="A=655-715"/>
</dbReference>
<dbReference type="PDB" id="2DAK">
<property type="method" value="NMR"/>
<property type="chains" value="A=723-772"/>
</dbReference>
<dbReference type="PDB" id="2G43">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.09"/>
<property type="chains" value="A/B=163-291"/>
</dbReference>
<dbReference type="PDB" id="2G45">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.99"/>
<property type="chains" value="A/D=163-291"/>
</dbReference>
<dbReference type="PDB" id="3IHP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B=1-858"/>
</dbReference>
<dbReference type="PDBsum" id="2DAG"/>
<dbReference type="PDBsum" id="2DAK"/>
<dbReference type="PDBsum" id="2G43"/>
<dbReference type="PDBsum" id="2G45"/>
<dbReference type="PDBsum" id="3IHP"/>
<dbReference type="ProteinModelPortal" id="P45974"/>
<dbReference type="SMR" id="P45974"/>
<dbReference type="BioGrid" id="113751">
<property type="interactions" value="81"/>
</dbReference>
<dbReference type="DIP" id="DIP-34459N"/>
<dbReference type="IntAct" id="P45974">
<property type="interactions" value="13"/>
</dbReference>
<dbReference type="MINT" id="MINT-5001006"/>
<dbReference type="STRING" id="9606.ENSP00000229268"/>
<dbReference type="BindingDB" id="P45974"/>
<dbReference type="ChEMBL" id="CHEMBL6158"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2431"/>
<dbReference type="MEROPS" id="C19.001"/>
<dbReference type="iPTMnet" id="P45974"/>
<dbReference type="PhosphoSitePlus" id="P45974"/>
<dbReference type="SwissPalm" id="P45974"/>
<dbReference type="BioMuta" id="USP5"/>
<dbReference type="DMDM" id="1717869"/>
<dbReference type="REPRODUCTION-2DPAGE" id="IPI00375145"/>
<dbReference type="EPD" id="P45974"/>
<dbReference type="MaxQB" id="P45974"/>
<dbReference type="PaxDb" id="P45974"/>
<dbReference type="PeptideAtlas" id="P45974"/>
<dbReference type="PRIDE" id="P45974"/>
<dbReference type="DNASU" id="8078"/>
<dbReference type="Ensembl" id="ENST00000229268">
<molecule id="P45974-1"/>
<property type="protein sequence ID" value="ENSP00000229268"/>
<property type="gene ID" value="ENSG00000111667"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000389231">
<molecule id="P45974-2"/>
<property type="protein sequence ID" value="ENSP00000373883"/>
<property type="gene ID" value="ENSG00000111667"/>
</dbReference>
<dbReference type="GeneID" id="8078"/>
<dbReference type="KEGG" id="hsa:8078"/>
<dbReference type="UCSC" id="uc001qrh.5">
<molecule id="P45974-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="8078"/>
<dbReference type="DisGeNET" id="8078"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000111667.13"/>
<dbReference type="GeneCards" id="USP5"/>
<dbReference type="HGNC" id="HGNC:12628">
<property type="gene designation" value="USP5"/>
</dbReference>
<dbReference type="HPA" id="HPA006756"/>
<dbReference type="MIM" id="601447">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P45974"/>
<dbReference type="OpenTargets" id="ENSG00000111667"/>
<dbReference type="PharmGKB" id="PA37253"/>
<dbReference type="eggNOG" id="KOG0944">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG5207">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000000874"/>
<dbReference type="HOGENOM" id="HOG000162311"/>
<dbReference type="HOVERGEN" id="HBG002833"/>
<dbReference type="InParanoid" id="P45974"/>
<dbReference type="KO" id="K11836"/>
<dbReference type="OMA" id="QQWDGEV"/>
<dbReference type="OrthoDB" id="EOG091G01W3"/>
<dbReference type="PhylomeDB" id="P45974"/>
<dbReference type="TreeFam" id="TF300576"/>
<dbReference type="BRENDA" id="3.4.19.12">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5689880">
<property type="pathway name" value="Ub-specific processing proteases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8866652">
<property type="pathway name" value="Synthesis of active ubiquitin: roles of E1 and E2 enzymes"/>
</dbReference>
<dbReference type="ChiTaRS" id="USP5">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P45974"/>
<dbReference type="GeneWiki" id="USP5"/>
<dbReference type="GenomeRNAi" id="8078"/>
<dbReference type="PMAP-CutDB" id="P45974"/>
<dbReference type="PRO" id="PR:P45974"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 12"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000111667"/>
<dbReference type="CleanEx" id="HS_USP5"/>
<dbReference type="ExpressionAtlas" id="P45974">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P45974">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005764">
<property type="term" value="C:lysosome"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0004197">
<property type="term" value="F:cysteine-type endopeptidase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0004843">
<property type="term" value="F:thiol-dependent ubiquitin-specific protease activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0036459">
<property type="term" value="F:thiol-dependent ubiquitinyl hydrolase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043130">
<property type="term" value="F:ubiquitin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0032436">
<property type="term" value="P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016579">
<property type="term" value="P:protein deubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071108">
<property type="term" value="P:protein K48-linked deubiquitination"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016567">
<property type="term" value="P:protein ubiquitination"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006511">
<property type="term" value="P:ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.40.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR001394">
<property type="entry name" value="Peptidase_C19_UCH"/>
</dbReference>
<dbReference type="InterPro" id="IPR015940">
<property type="entry name" value="UBA"/>
</dbReference>
<dbReference type="InterPro" id="IPR009060">
<property type="entry name" value="UBA-like_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR016652">
<property type="entry name" value="Ubiquitinyl_hydrolase"/>
</dbReference>
<dbReference type="InterPro" id="IPR018200">
<property type="entry name" value="USP_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR028889">
<property type="entry name" value="USP_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR013083">
<property type="entry name" value="Znf_RING/FYVE/PHD"/>
</dbReference>
<dbReference type="InterPro" id="IPR001607">
<property type="entry name" value="Znf_UBP"/>
</dbReference>
<dbReference type="Pfam" id="PF00627">
<property type="entry name" value="UBA"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF00443">
<property type="entry name" value="UCH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02148">
<property type="entry name" value="zf-UBP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF016308">
<property type="entry name" value="UBP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00165">
<property type="entry name" value="UBA"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00290">
<property type="entry name" value="ZnF_UBP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF46934">
<property type="entry name" value="SSF46934"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50030">
<property type="entry name" value="UBA"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS00972">
<property type="entry name" value="USP_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00973">
<property type="entry name" value="USP_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50235">
<property type="entry name" value="USP_3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50271">
<property type="entry name" value="ZF_UBP"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0645">Protease</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0788">Thiol protease</keyword>
<keyword id="KW-0833">Ubl conjugation pathway</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="initiator methionine" description="Removed" evidence="3 6 7">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Ubiquitin carboxyl-terminal hydrolase 5" id="PRO_0000080623">
<location>
<begin position="2"/>
<end position="858"/>
</location>
</feature>
<feature type="domain" description="USP">
<location>
<begin position="326"/>
<end position="856"/>
</location>
</feature>
<feature type="domain" description="UBA 1" evidence="12">
<location>
<begin position="654"/>
<end position="695"/>
</location>
</feature>
<feature type="domain" description="UBA 2" evidence="12">
<location>
<begin position="722"/>
<end position="762"/>
</location>
</feature>
<feature type="zinc finger region" description="UBP-type" evidence="13">
<location>
<begin position="197"/>
<end position="269"/>
</location>
</feature>
<feature type="region of interest" description="Substrate binding">
<location>
<begin position="221"/>
<end position="224"/>
</location>
</feature>
<feature type="active site" description="Nucleophile">
<location>
<position position="335"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="14 15">
<location>
<position position="818"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc">
<location>
<position position="199"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc">
<location>
<position position="202"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc">
<location>
<position position="219"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc">
<location>
<position position="232"/>
</location>
</feature>
<feature type="binding site" description="Substrate">
<location>
<position position="209"/>
</location>
</feature>
<feature type="binding site" description="Substrate">
<location>
<position position="259"/>
</location>
</feature>
<feature type="binding site" description="Substrate; via carbonyl oxygen">
<location>
<position position="261"/>
</location>
</feature>
<feature type="binding site" description="Substrate">
<location>
<position position="264"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylalanine" evidence="3 6 7">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="156"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="8">
<location>
<position position="292"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="11">
<location>
<position position="623"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="779"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 5 8">
<location>
<position position="783"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="785"/>
</location>
</feature>
<feature type="disulfide bond" evidence="20">
<location>
<begin position="195"/>
<end position="816"/>
</location>
</feature>
<feature type="splice variant" description="In isoform Short." id="VSP_005259" evidence="21">
<original>GSLGFYGNEDEDSFCSPHFSSPTS</original>
<variation>A</variation>
<location>
<begin position="629"/>
<end position="652"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased rate of activity and decreased zinc binding." evidence="16">
<original>C</original>
<variation>A</variation>
<location>
<position position="199"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased rate of activity." evidence="16">
<original>C</original>
<variation>A</variation>
<location>
<position position="202"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased rate of activity." evidence="16">
<original>C</original>
<variation>A</variation>
<location>
<position position="219"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of polyubiquitin binding and subsequent activation." evidence="19">
<original>RRY</original>
<variation>KWF</variation>
<location>
<begin position="221"/>
<end position="223"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of polyubiquitin hydrolysis. Loss of ubiquitin binding; when associated with A-335." evidence="17">
<original>R</original>
<variation>A</variation>
<location>
<position position="221"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased rate of activity." evidence="16">
<original>H</original>
<variation>A</variation>
<location>
<position position="232"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of polyubiquitin binding." evidence="19">
<original>Y</original>
<variation>F</variation>
<location>
<position position="261"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of activity. Loss of ubiquitin binding; when associated with A-221. Lower affinity for triubiquitin and tetraubiquitin, but no effect on affinity for diubiquitin; when associated with E-666. Lower affinity for diubiquitin, triubiquitin and tetraubiquitin; when associated with E-734." evidence="17">
<original>C</original>
<variation>A</variation>
<location>
<position position="335"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of polyubiquitin binding and hydrolysis." evidence="17">
<original>D</original>
<variation>A</variation>
<location>
<position position="435"/>
</location>
</feature>
<feature type="mutagenesis site" description="Lower affinity for triubiquitin and tetraubiquitin, but no effect on affinity for diubiquitin; when associated with A-335. No effect on activity; when associated with E-734." evidence="17">
<original>M</original>
<variation>E</variation>
<location>
<position position="666"/>
</location>
</feature>
<feature type="mutagenesis site" description="Lower affinity for diubiquitin, triubiquitin and tetraubiquitin; when associated with A-335. No effect on activity; when associated with E-666." evidence="17">
<original>M</original>
<variation>E</variation>
<location>
<position position="734"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA62690." ref="1" evidence="22">
<original>EL</original>
<variation>DV</variation>
<location>
<begin position="3"/>
<end position="4"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA62690." ref="1" evidence="22">
<original>I</original>
<variation>V</variation>
<location>
<position position="45"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAA78934." ref="4" evidence="22">
<original>K</original>
<variation>R</variation>
<location>
<position position="468"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAA78934." ref="4" evidence="22">
<original>G</original>
<variation>D</variation>
<location>
<position position="681"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="5"/>
<end position="11"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="12"/>
<end position="15"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="31"/>
<end position="34"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="43"/>
<end position="46"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="47"/>
<end position="49"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="55"/>
<end position="57"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="58"/>
<end position="65"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="69"/>
<end position="75"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="118"/>
<end position="124"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="125"/>
<end position="128"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="129"/>
<end position="131"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="141"/>
<end position="154"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="178"/>
<end position="182"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="200"/>
<end position="203"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="206"/>
<end position="211"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="212"/>
<end position="214"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="217"/>
<end position="219"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="232"/>
<end position="240"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="244"/>
<end position="247"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="258"/>
<end position="260"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="261"/>
<end position="264"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="265"/>
<end position="268"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="272"/>
<end position="277"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="278"/>
<end position="280"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="283"/>
<end position="285"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="335"/>
<end position="344"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="348"/>
<end position="354"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="355"/>
<end position="357"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="358"/>
<end position="364"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="369"/>
<end position="371"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="373"/>
<end position="385"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="415"/>
<end position="421"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="422"/>
<end position="424"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="426"/>
<end position="429"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="430"/>
<end position="432"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="436"/>
<end position="449"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="457"/>
<end position="460"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="463"/>
<end position="471"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="472"/>
<end position="475"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="476"/>
<end position="489"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="493"/>
<end position="495"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="499"/>
<end position="514"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="529"/>
<end position="537"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="540"/>
<end position="547"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="548"/>
<end position="551"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="552"/>
<end position="564"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="567"/>
<end position="573"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="576"/>
<end position="578"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="580"/>
<end position="582"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="584"/>
<end position="586"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="595"/>
<end position="598"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="600"/>
<end position="602"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="658"/>
<end position="666"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="670"/>
<end position="679"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="685"/>
<end position="695"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="700"/>
<end position="702"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="725"/>
<end position="732"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="733"/>
<end position="735"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="738"/>
<end position="747"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="748"/>
<end position="750"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="752"/>
<end position="770"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="799"/>
<end position="812"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="818"/>
<end position="825"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="828"/>
<end position="833"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="836"/>
<end position="839"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="849"/>
<end position="855"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2G45"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3IHP"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19413330"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22223895"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000250"/>
<evidence key="11" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P56399"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00212"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00502"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10092"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10093"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16564012"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18482987"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19098288"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22216260"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source ref="23"/>
</evidence>
<evidence key="21" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000305"/>
<sequence length="858" mass="95786" checksum="E99CB7CDFA682C65" modified="1996-10-01" version="2">
MAELSEEALLSVLPTIRVPKAGDRVHKDECAFSFDTPESEGGLYICMNTFLGFGKQYVER
HFNKTGQRVYLHLRRTRRPKEEDPATGTGDPPRKKPTRLAIGVEGGFDLSEEKFELDEDV
KIVILPDYLEIARDGLGGLPDIVRDRVTSAVEALLSADSASRKQEVQAWDGEVRQVSKHA
FSLKQLDNPARIPPCGWKCSKCDMRENLWLNLTDGSILCGRRYFDGSGGNNHAVEHYRET
GYPLAVKLGTITPDGADVYSYDEDDMVLDPSLAEHLSHFGIDMLKMQKTDKTMTELEIDM
NQRIGEWELIQESGVPLKPLFGPGYTGIRNLGNSCYLNSVVQVLFSIPDFQRKYVDKLEK
IFQNAPTDPTQDFSTQVAKLGHGLLSGEYSKPVPESGDGERVPEQKEVQDGIAPRMFKAL
IGKGHPEFSTNRQQDAQEFFLHLINMVERNCRSSENPNEVFRFLVEEKIKCLATEKVKYT
QRVDYIMQLPVPMDAALNKEELLEYEEKKRQAEEEKMALPELVRAQVPFSSCLEAYGAPE
QVDDFWSTALQAKSVAVKTTRFASFPDYLVIQIKKFTFGLDWVPKKLDVSIEMPEELDIS
QLRGTGLQPGEEELPDIAPPLVTPDEPKGSLGFYGNEDEDSFCSPHFSSPTSPMLDESVI
IQLVEMGFPMDACRKAVYYTGNSGAEAAMNWVMSHMDDPDFANPLILPGSSGPGSTSAAA
DPPPEDCVTTIVSMGFSRDQALKALRATNNSLERAVDWIFSHIDDLDAEAAMDISEGRSA
ADSISESVPVGPKVRDGPGKYQLFAFISHMGTSTMCGHYVCHIKKEGRWVIYNDQKVCAS
EKPPKDLGYIYFYQRVAS
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>